Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.555 USD | -0.96% | +7.82% | -85.42% |
02:57pm | Earnings Flash (MRNS) MARINUS PHARMACEUTICALS Reports Q1 Revenue $7.7M, vs. Street Est of $9.1M | MT |
01:00pm | Marinus Pharmaceuticals, Inc. Increases Earnings Guidance for Full Year 2024 | CI |
Financials (USD)
Sales 2024 * | 40.73M | Sales 2025 * | 59.61M | Capitalization | 86.23M |
---|---|---|---|---|---|
Net income 2024 * | -132M | Net income 2025 * | -91M | EV / Sales 2024 * | 2.12 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.45 x |
P/E ratio 2024 * |
-0.71
x | P/E ratio 2025 * |
-1.24
x | Employees | 166 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.02% |
Latest transcript on Marinus Pharmaceuticals, Inc.
1 day | -1.91% | ||
1 week | +11.35% | ||
Current month | +11.35% | ||
1 month | -79.87% | ||
3 months | -84.16% | ||
6 months | -75.88% | ||
Current year | -85.56% |
Managers | Title | Age | Since |
---|---|---|---|
Scott Braunstein
CEO | Chief Executive Officer | 60 | 18-09-04 |
Steven Pfanstiel
DFI | Director of Finance/CFO | 51 | 21-04-11 |
Joseph Hulihan
CTO | Chief Tech/Sci/R&D Officer | 68 | 19-11-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tim Mayleben
BRD | Director/Board Member | 63 | 08-11-30 |
Scott Braunstein
CEO | Chief Executive Officer | 60 | 18-09-04 |
Elan Ezickson
BRD | Director/Board Member | 60 | 19-12-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.96% | 11 M€ | -6.03% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 1.585 | +0.96% | 1 191 067 |
24-05-07 | 1.57 | +6.08% | 1,304,147 |
24-05-06 | 1.48 | -1.99% | 1,574,489 |
24-05-03 | 1.51 | +4.14% | 1,620,694 |
24-05-02 | 1.45 | -1.36% | 989,641 |
Delayed Quote Nasdaq, May 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-85.56% | 86.23M | |
+33.43% | 700B | |
-5.12% | 358B | |
+19.59% | 330B | |
+4.89% | 287B | |
+15.84% | 236B | |
+6.81% | 202B | |
-9.08% | 197B | |
+4.26% | 161B | |
-3.54% | 157B |
- Stock Market
- Equities
- MRNS Stock